Patent Assignment Assignor Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Assignor Name :
OWENS, CHRISTINA
|
|
Total Assignments:
3
|
|
Assignment:
1
|
| |
|
| Reel/Frame: | 051947/0921 | |
| Pages: | 9 |
| | Recorded: | 02/27/2020 | | |
| Attorney Dkt #: | P-346-US1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Assignee
|
|
|
|
|
| 901 GATEWAY BLVD. |
| SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
|
|
Pat #
|
Pub #
|
Intl #
|
App #
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16708926
|
|
Correspondence name and address
|
| |
THERAVANCE BIOPHARMA US, INC.
|
| |
901 GATEWAY BLVD.
|
| |
SOUTH SAN FRANCISCO, CA 94080
|
|
|
Assignment:
2
|
| |
|
| Reel/Frame: | 056389/0113 | |
| Pages: | 14 |
| | Recorded: | 05/28/2021 | | |
| Attorney Dkt #: | P-347-US1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Assignee
|
|
|
|
|
| 901 GATEWAY BLVD |
| SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
|
|
Pat #
|
Pub #
|
Intl #
|
App #
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16949915
|
|
Correspondence name and address
|
| |
THERAVANCE BIOPHARMA US, INC.
|
| |
901 GATEWAY BLVD
|
| |
SOUTH SAN FRANCISCO, CA 94080
|
|
|
Assignment:
3
|
| |
|
| Reel/Frame: | 062248/0106 | |
| Pages: | 11 |
| | Recorded: | 12/30/2022 | | |
| Attorney Dkt #: | 71TD-343528-US |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Assignee
|
|
|
|
|
| 901 GATEWAY BLVD. |
| SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
|
|
Pat #
|
Pub #
|
Intl #
|
App #
|
|
|
|
|
|
|
|
|
|
|
|
|
NONE
|
|
|
17848724
|
|
Correspondence name and address
|
| |
LORNA L. TANNER
|
| |
SHEPPARD MULLIN RICHTER & HAMPTON LLP
|
| |
650 TOWN CENTER DRIVE, 10TH FLOOR
|
| |
COSTA MESA, CA 92626-1993
|
|
Search Results as of:
05/23/2024 11:43 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
